Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Xiang

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Tumori|February 7, 2006
Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumorMeiqing Shi, Liping Su, Sigou Hao, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunityYufeng Xie, Ou Bai, Haifeng Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Adenovirus-mediated Il-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesisXiaohua Wang, Zhenmin Ye, Jiang Zhong, et al.
Journal of Opioid Management|July 21, 2010
Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis painGary Vorsanger, Jim Xiang, Akiko Okamoto, et al.
Cellular & Molecular Immunology|May 1, 2008
Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansionZhenmin Ye, Shulin Xu, Terence Moyana, et al.
Cellular & Molecular Immunology|August 9, 2006
Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomesSiguo Hao, Ou Bai, Jinying Yuan, et al.
The Journal of Gene Medicine|August 5, 2003
Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunityYongqing Liu, Hui Huang, Zhuang Chen, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunitySiguo Hao, Zhenmin Ye, Jicheng Yang, et al.
Cellular & Molecular Immunology|September 3, 2008
Intercellular trogocytosis plays an important role in modulation of immune responsesKhawaja Ashfaque Ahmed, Manjunatha Ankathatti Munegowda, Yufeng Xie, et al.
Biochemical and Biophysical Research Communications|September 7, 2007
CD4+ T cell acquisition of the bystander pMHC I colocalizing in the same immunological synapse comprising pMHC II and costimulatory CD40, CD54, CD80, OX40L, and 41BBLTianpei He, Sam Zong, Xiaochu Wu, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Tumori|February 7, 2006
Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumorMeiqing Shi, Liping Su, Sigou Hao, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunityYufeng Xie, Ou Bai, Haifeng Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Adenovirus-mediated Il-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesisXiaohua Wang, Zhenmin Ye, Jiang Zhong, et al.
Journal of Opioid Management|July 21, 2010
Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis painGary Vorsanger, Jim Xiang, Akiko Okamoto, et al.
Cellular & Molecular Immunology|May 1, 2008
Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansionZhenmin Ye, Shulin Xu, Terence Moyana, et al.
Cellular & Molecular Immunology|August 9, 2006
Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomesSiguo Hao, Ou Bai, Jinying Yuan, et al.
The Journal of Gene Medicine|August 5, 2003
Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunityYongqing Liu, Hui Huang, Zhuang Chen, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunitySiguo Hao, Zhenmin Ye, Jicheng Yang, et al.
Cellular & Molecular Immunology|September 3, 2008
Intercellular trogocytosis plays an important role in modulation of immune responsesKhawaja Ashfaque Ahmed, Manjunatha Ankathatti Munegowda, Yufeng Xie, et al.
Biochemical and Biophysical Research Communications|September 7, 2007
CD4+ T cell acquisition of the bystander pMHC I colocalizing in the same immunological synapse comprising pMHC II and costimulatory CD40, CD54, CD80, OX40L, and 41BBLTianpei He, Sam Zong, Xiaochu Wu, et al.
Pageof 17